<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="370557">
  <stage>Registered</stage>
  <submitdate>19/04/2016</submitdate>
  <approvaldate>26/05/2016</approvaldate>
  <actrnumber>ACTRN12616000699460</actrnumber>
  <trial_identification>
    <studytitle>Screening for foveal pathology in an adult population using non-mydriatic spectral domain optical coherence tomography</studytitle>
    <scientifictitle>Screening for foveal pathology in an adult population using non-mydriatic spectral domain optical coherence tomography</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Foveal pathology</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Diseases / disorders of the eye</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Assessment entails a non-mydriatic optical coherence tomography in addition to a comprehensive ophthalmologic evaluation done at the military hospital for adult subjects who happen to be accompanying patients.  This single assessment session lasts about 90 minutes  It is not repeated.  The non mydriatic OCT image is sent to a reading center electronically to be evaluated by a reader.  </interventions>
    <comparator>no control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Early Detection / Screening</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Rate of detection of irregularities in the foveal area assessed by non-mydriatic Optical Coherence Tomography.</outcome>
      <timepoint>90 minutes.  Each participant will have one assessment session, starting with a non-mydriatic optical coherence tomography only to be followed by a comprehensive eye evaluation.  </timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>best corrected visual acuity using the ETDRS chart.</outcome>
      <timepoint>15 minute; this outcome is assessed at study entry as part of the comprehensive eye examination that each study subject receives.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Thickness of the fovea using the non-mydriatic optical coherence tomography</outcome>
      <timepoint>15 minutes; this is measured during the image interpretation of the acquired NMOCT by the retina specialist in the reading center.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>healthy adult willing to undergo a comprehensive eye examination</inclusivecriteria>
    <inclusiveminage>50</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>patients who are not willing to undergo a comprehensive dilated eye examination</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>Ideally we would like to screen around 500 eyes, since these abnormalities have been detected in 9% or so in general population using a comprehensive eye examination.  Around 250 participant would be needed to look for asymptomatic irregularities in the fovea.  Sensitivity, specificity, positive predictive value, negative predictive value, kappa coefficient</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Random sample</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate />
    <actualstartdate>11/02/2015</actualstartdate>
    <anticipatedenddate>10/02/2017</anticipatedenddate>
    <actualenddate />
    <samplesize>250</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Lebanon</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Haytham Salti</primarysponsorname>
    <primarysponsoraddress>American University of Beirut Medical Center
Maamari Street
Beirut
LEBANON
 110236</primarysponsoraddress>
    <primarysponsorcountry>Lebanon</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Haytham Salti</fundingname>
      <fundingaddress>American University of Beirut Medical Center 
Maamari street 
Beirut LEBANON
 110236</fundingaddress>
      <fundingcountry>Lebanon</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>American University of Beirut Medical Center </sponsorname>
      <sponsoraddress>Maamari Street
Beirut, LEBANON
110236</sponsoraddress>
      <sponsorcountry>Lebanon</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Purpose: To evaluate non-mydriatic spectral domain optical coherence tomography (NMOCT) as a telemedicine screening tool for adult foveal abnormalities.

Materials and Methods: two hundred and fifty  middle-aged subjects will be asked to undergo a NMOCT test. These subjects will also be invited to undergo a comprehensive ophthalmologic evaluation to check for the efficacy of the NMOCT as a telemedicine screening tool in detecting foveal abnormalities.  
</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>IRB-Military Hospital Badaro </ethicname>
      <ethicaddress>IRB Military Hospital
Badaro street, Beirut</ethicaddress>
      <ethicapprovaldate>11/01/2014</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>11/12/2013</ethicsubmitdate>
      <ethiccountry>Lebanon</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Haytham Salti</name>
      <address>American University of Beirut Medical Center
Maamari Street
110236</address>
      <phone>+9613776683</phone>
      <fax>+9611370837</fax>
      <email>hs06@aub.edu.lb</email>
      <country>Lebanon</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Maamoun Abdul Fattah</name>
      <address>American University of Beirut Medical Center
Maamari Street
Beirut LEBANON
 110236</address>
      <phone>+96178845330</phone>
      <fax />
      <email>ma318@aub.edu.lb</email>
      <country>Lebanon</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Haytham Salti</name>
      <address>American University of Beirut Medical Center
Maamari Street
Beirut LEBANON
110236</address>
      <phone>+9613776683</phone>
      <fax />
      <email>hs06@aub.edu.lb</email>
      <country>Lebanon</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>